Abstract:Establishing and maintaining a healthy endothelium on vascular and intravascular devices is crucial for the prevention of thrombosis and stenosis. Generating a biofunctional surface on vascular devices to recruit endothelial progenitor cells (EPCs) and endothelial cells (ECs) has proven efficient in promoting in situ endothelialization. However, molecules conventionally used for EPC/EC capturing generally lack structural stability, capturing specificity, and biological functionalities, which have limited their applications. Discovery of effective, specific, and structurally stable EPC/EC capturing ligands is desperately needed. Using the high-throughput One-Bead One-Compound combinatorial library screening technology, we recently identified a disulfide cyclic octa-peptide LXW7 (cGRGDdvc), which possesses strong binding affinity and functionality to EPCs/ECs, weak binding to platelets, and no binding to inflammatory cells. Because LXW7 is cyclic and 4 out of the 8 amino acids are unnatural D-amino acids, LXW7 is highly proteolytically stable. In this study, we applied LXW7 to modify small diameter vascular grafts using a Click chemistry approach. In vitro studies demonstrated that LXW7-modified grafts significantly improved EPC attachment, proliferation and endothelial differentiation and suppressed platelet attachment. In a rat carotid artery bypass model, LXW7 modification of the small diameter vascular grafts significantly promoted EPC/EC recruitment and rapidly achieved endothelialization. At 6 weeks after implantation, LXW7-modified grafts retained a high patency of 83%, while the untreated grafts had a low patency of 17%. Our results demonstrate that LXW7 is a potent EPC/EC capturing and platelet suppressing ligand and LXW7-modified vascular grafts rapidly generate a healthy and stable endothelial interface between the graft surface and the circulation to reduce thrombosis and improve patency. STATEMENT OF SIGNIFICANCE: In this study, One-Bead One-Compound (OBOC) technology has been applied for the first time in discovering bioactive ligands for tissue regeneration applications. Current molecules used to modify artificial vascular grafts generally lack EPC/EC capturing specificity, biological functionalities and structural stability. Using OBOC technology, we identified LXW7, a constitutionally stable disulfide cyclic octa-peptide with strong binding affinity and biological functionality to EPCs/ECs, very weak binding to platelets and no binding to inflammatory cells. These characteristics are crucial for promoting rapid endothelialization to prevent thrombosis and improve patency of vascular grafts. LXW7 coating technology could be applied to a wide range of vascular and intravascular devices, including grafts, stents, cardiac valves, and catheters, where a "living" endothelium and healthy blood interface are needed.

Site-directed Immobilization of Antibodies Onto Blood Contacting Grafts for Enhanced Endothelial Cell Adhesion and Proliferation

Plasma-Mediated Immobilization of Antibody with PEG As Spacer for Enhanced Endothelial Cell Adhesion and Proliferation

Development of a universal, oriented antibody immobilization method to functionalize vascular prostheses for enhanced endothelialization for potential clinical application

Combinatorial coating of adhesive polypeptide and anti-CD34 antibody for improved endothelial cell adhesion and proliferation

Immobilization of CD34 Antibodies onto 316L Stainless Steel and in vitro Cytocompatibility

Immobilization of serum albumin and peptide aptamer for EPC on polydopamine coated titanium surface for enhanced in-situ self-endothelialization.

[Immobilization of CD34 Antibodies Onto Ethylene-Vinyl Acetate Copolymer Coatings and in Vitro Cell Attachments].

Co-immobilization of CD133 Antibodies, Vascular Endothelial Growth Factors, and REDV Peptide Promotes Capture, Proliferation, and Differentiation of Endothelial Progenitor Cells.

Direct Adsorption of Anti-CD34 Antibodies on the Nano-Porous Stent Surface to Enhance Endothelialization.

Immobilization of Anti-Cd31 Antibody on Electrospun Poly(ɛ-Caprolactone) Scaffolds Through Hydrophobins for Specific Adhesion of Endothelial Cells.

Preparation of Vascular Endothelial Cadherin Loaded-Amphoteric Copolymer Decorated Coronary Stents for Anticoagulation and Endothelialization

Immobilization of Glycogen Synthase Kinase-3β Inhibitor on 316L Stainless Steel via Polydopamine to Accelerate Endothelialization

Immobilization of Glycogen Synthase Kinase-3 Inhibitor on 316L Stainless Steel <i>via</i> Polydopamine to Accelerate Endothelialization

Fabrication of Endothelial Progenitor Cell Capture Surface Via DNA Aptamer Modifying Dopamine/polyethyleneimine Copolymer Film

Tailoring of the dopamine coated surface with VEGF loaded heparin/poly-L-lysine particles for anticoagulation and accelerate in situ endothelialization.

Synthetic Eptfe Grafts Coated with an Anti-Cd133 Antibody-Functionalized Heparin/collagen Multilayer with Rapid in Vivo Endothelialization Properties.

Amelioration of Blood Compatibility and Endothelialization of Polycaprolactone Substrates by Surface-Initiated Atom Transfer Radical Polymerization

Tannic Acid-Assisted Immobilization of Copper(II), Carboxybetaine, and Argatroban on Poly(ethylene Terephthalate) Mats for Synergistic Improvement of Blood Compatibility and Endothelialization.

Anti-Cd34 Antibody Functionalized Swollen Polymeric Coating for Endothelial Cell Rapid Selectively Capture

Cooperative Control of Blood Compatibility and Re-Endothelialization by Immobilized Heparin and Substrate Topography.

Rapid Endothelialization of Small Diameter Vascular Grafts by a Bioactive Integrin-Binding Ligand Specifically Targeting Endothelial Progenitor Cells and Endothelial Cells.